Wu JC - Search Results

1

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.

Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. Nishiga M, et al. Among authors: wu jc. Nat Rev Cardiol. 2020 Sep;17(9):543-558. doi: 10.1038/s41569-020-0413-9. Epub 2020 Jul 20. Nat Rev Cardiol. 2020. PMID: 32690910 Free PMC article. Review.

2

Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.

Chen IY, Matsa E, Wu JC. Chen IY, et al. Among authors: wu jc. Nat Rev Cardiol. 2016 Jun;13(6):333-49. doi: 10.1038/nrcardio.2016.36. Epub 2016 Mar 24. Nat Rev Cardiol. 2016. PMID: 27009425 Free PMC article. Review.

3

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

Nishiga M, Guo H, Wu JC. Nishiga M, et al. Among authors: wu jc. Eur Heart J. 2018 May 21;39(20):1848-1850. doi: 10.1093/eurheartj/ehy097. Eur Heart J. 2018. PMID: 29547885 Free PMC article. No abstract available.

4

Dyslipidaemia: In vivo genome editing of ANGPTL3: a therapy for atherosclerosis?

Rhee JW, Wu JC. Rhee JW, et al. Among authors: wu jc. Nat Rev Cardiol. 2018 May;15(5):259-260. doi: 10.1038/nrcardio.2018.38. Epub 2018 Apr 5. Nat Rev Cardiol. 2018. PMID: 29618844 Free PMC article.

5

Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics.

Paik DT, Chandy M, Wu JC. Paik DT, et al. Among authors: wu jc. Pharmacol Rev. 2020 Jan;72(1):320-342. doi: 10.1124/pr.116.013003. Pharmacol Rev. 2020. PMID: 31871214 Free PMC article. Review.

6

Therapeutic genome editing in cardiovascular diseases.

Nishiga M, Qi LS, Wu JC. Nishiga M, et al. Among authors: wu jc. Adv Drug Deliv Rev. 2021 Jan;168:147-157. doi: 10.1016/j.addr.2020.02.003. Epub 2020 Feb 21. Adv Drug Deliv Rev. 2021. PMID: 32092381 Free PMC article. Review.

7

Single-cell RNA sequencing in cardiovascular development, disease and medicine.

Paik DT, Cho S, Tian L, Chang HY, Wu JC. Paik DT, et al. Among authors: wu jc. Nat Rev Cardiol. 2020 Aug;17(8):457-473. doi: 10.1038/s41569-020-0359-y. Epub 2020 Mar 30. Nat Rev Cardiol. 2020. PMID: 32231331 Free PMC article. Review.

8

Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty.

Cheng P, Zhu H, Witteles RM, Wu JC, Quertermous T, Wu SM, Rhee JW. Cheng P, et al. Among authors: wu jc, wu sm. Curr Cardiol Rep. 2020 Apr 29;22(5):34. doi: 10.1007/s11886-020-01293-2. Curr Cardiol Rep. 2020. PMID: 32350632 Free PMC article. Review.

9

Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19.

Nishiga M, Wu JC. Nishiga M, et al. Among authors: wu jc. Circ Res. 2021 Jun 25;129(1):47-49. doi: 10.1161/CIRCRESAHA.121.319446. Epub 2021 Jun 24. Circ Res. 2021. PMID: 34166080 Free PMC article. No abstract available.

10

CRISPRi/a Screening with Human iPSCs.

Nishiga M, Qi LS, Wu JC. Nishiga M, et al. Among authors: wu jc. Methods Mol Biol. 2021;2320:261-281. doi: 10.1007/978-1-0716-1484-6_23. Methods Mol Biol. 2021. PMID: 34302664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,386 results

Search Page